BRENDA-Score, a Highly Significant, Internally and Externally Validated Prognostic Marker for Metastatic Recurrence: Analysis of 10,449 Primary Breast Cancer Patients

by Manfred Wischnewsky, Lukas Schwentner, Joachim Diessner, Amelie de Gregorio, Ralf Joukhadar, Dayan Davut, Jessica Salmen, Inga Bekes, Matthias Kiesel, Max Müller-Reiter, Maria Blettner, Regine Wolters, Wolfgang Janni, Rolf Kreienberg, Achim Wöckel, Florian Ebner
Published 2021-06-01

Gemcitabine as adjuvant chemotherapy in patients with high-risk early breast cancer—results from the randomized phase III SUCCESS-A trial

by Amelie de Gregorio, Lothar Häberle, Peter A. Fasching, Volkmar Müller, Iris Schrader, Ralf Lorenz, Helmut Forstbauer, Thomas W. P. Friedl, Emanuel Bauer, Nikolaus de Gregorio, Miriam Deniz, Visnja Fink, Inga Bekes, Ulrich Andergassen, Andreas Schneeweiss, Hans Tesch, Sven Mahner, Sara Y. Brucker, Jens-Uwe Blohmer, Tanja N. Fehm, Georg Heinrich, Krisztian Lato, Matthias W. Beckmann, Brigitte Rack, Wolfgang Janni
Published 2020-10-01